Search

In Stock

Buy Entresto (sacubitril/valsartan) Online

DISEASE INDICATIONS: Risk of cardiovascular events

MANUFACTURER: Novartis

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Entresto is a combination medication used to treat chronic heart failure in adults, containing sacubitril and valsartan.

From $148.92

Clear
Compare

Entresto is a combination medication that contains sacubitril and valsartan, used to treat heart failure in adults. Sacubitril is a neprilysin inhibitor that helps increase levels of beneficial peptides in the body, while valsartan is an angiotensin II receptor blocker that helps lower blood pressure.

Uses:

Entresto is used to treat chronic heart failure with reduced ejection fraction in adults who have symptoms despite receiving treatment with standard heart failure medications. It helps improve symptoms, reduce hospitalizations and the risk of cardiovascular death.

Storage Conditions:

Entresto should be stored at room temperature between 68°F and 77°F (20°C to 25°C). The medication should be kept in the original container and protected from light and moisture.

Mechanism of Action:

Sacubitril works by inhibiting the enzyme neprilysin which helps increase levels of beneficial peptides such as natriuretic peptides and angiotensin converting enzyme 2, leading to vasodilation and sodium excretion. Valsartan works by blocking the angiotensin II receptor, preventing blood vessels from constricting and reducing blood pressure.

HOW TO USE:

Entresto comes in tablet form and is taken orally twice a day with or without food. The dosage is determined by the healthcare provider and depends on the patient’s medical condition, renal function, and tolerability to the medication. Patients should follow the instructions on the prescription label and use the medication exactly as directed.

Important Safety Information:

• Entresto should not be used by patients who are allergic to sacubitril or valsartan or any of its components, or who have had a previous reaction to an angiotensin-converting enzyme (ACE) inhibitor.
• The medication should not be used during pregnancy as it may harm the fetus.
• The medication may increase the risk of hyperkalemia (high potassium levels) and patients with renal impairment or taking potassium-sparing diuretics should be monitored closely while taking the medication.
• The medication may also cause hypotension (low blood pressure), and patients should be monitored closely for symptoms such as dizziness or fainting.

Indications:

• Entresto is indicated for the treatment of chronic heart failure with reduced ejection fraction in adults who have symptoms despite receiving treatment with standard heart failure medications.

Precautions:

• Patients with a history of angioedema, a serious allergic reaction, should be monitored closely while taking Entresto.
• The medication should be used with caution in patients with a history of liver disease, diabetes, or renal impairment.

Interactions:

• The medication may interact with other medications such as potassium-sparing diuretics and nonsteroidal anti-inflammatory drugs (NSAIDs).
• Patients taking other medications that may increase potassium levels, such as ACE inhibitors or potassium supplements, should be closely monitored while taking Entresto.

Contraindications:

• Entresto is contraindicated in patients who are allergic to sacubitril or valsartan or any of its components, or who have had a previous reaction to an ACE inhibitor.
• The medication should not be used during pregnancy and breastfeeding.

Overdose:

In case of an overdose, patients should seek emergency medical attention immediately.

Side Effects:

The most common side effects of Entresto include hypotension, hyperkalemia, cough, and dizziness. Serious side effects may include angioedema, impaired kidney function, and fetal toxicity. Patients should notify their healthcare provider if they experience any unusual symptoms while taking Entresto.

In conclusion, Entresto is a combination medication used to treat chronic heart failure with reduced ejection fraction in adults. It works by inhibiting the enzyme neprilysin and blocking the angiotensin II receptor, leading to vasodilation and lower blood pressure. Entresto is taken orally twice a day and the dosage is determined by the healthcare provider. Patients should not use Entresto if they are allergic to sacubitril or valsartan or any of its components or if they have had a previous reaction to an ACE inhibitor. It may cause hyperkalemia, hypotension, and interact with other medications such as potassium-sparing diuretics and NSAIDs. Pregnant women and breastfeeding mothers should not use Entresto. Patients should seek emergency medical attention in case of overdose and notify their healthcare provider of any unusual symptoms.

Package

56 tablets of 24 mg/26 mg, 56 tablets of 49 mg/51 mg, 56 tablets of 97 mg/103 mg, 196 tablets of 24 mg/26 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Entresto (sacubitril/valsartan) Online

From $148.92
(0 Reviews)
DISEASE INDICATIONS: Risk of cardiovascular events MANUFACTURER: Novartis USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Entresto is a combination medication used to treat chronic heart failure in adults, containing sacubitril and valsartan.

Buy Nexletol (bempedoic acid) Online

$426.42
(0 Reviews)
DISEASE INDICATIONS: Hypercholesterolemia MANUFACTURER: Esperion Therapeutics USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Nexletol is a prescription medication used to lower cholesterol levels in patients with hypercholesterolemia.

Buy Orladeyo (berotralstat) Online

$17,967.38
(0 Reviews)
MANUFACTURER: BioCryst Pharmaceuticals USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Orladeyo is a prescription medication used to prevent attacks of hereditary angioedema in adults and children by reducing the frequency of attacks. It is a subcutaneous injection that works by inhibiting kallikrein, an enzyme involved in the production of bradykinin.

Buy Verquvo (vericiguat) Online

From $284.99
(0 Reviews)
DISEASE INDICATIONS: Risk of cardiovascular events MANUFACTURER: Merck USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Verquvo (vericiguat) is a prescription medication used to treat chronic heart failure (CHF) with reduced ejection fraction (HFrEF). CHF is a condition in which the heart muscle is weakened and cannot pump blood as efficiently as it should. HFrEF is a type of CHF in which the left ventricle of the heart is not pumping blood as well as it should.

Buy Repatha SureClick (evolocumab) Online

$629.98
(0 Reviews)
DISEASE INDICATIONS: Risk of cardiovascular events, Hypercholesterolemia MANUFACTURER: Amgen Inc. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Repatha is a subcutaneous injection used to lower LDL cholesterol levels in adults with primary hyperlipidemia or mixed dyslipidemia and in individuals with clinical atherosclerotic cardiovascular disease who require additional LDL cholesterol reduction. It binds to and inhibits PCSK9, promoting the clearance of LDL cholesterol from the bloodstream.

Buy Vascepa (icosapent ethyl) Online

From $530.34
(0 Reviews)
DISEASE INDICATIONS: Risk of cardiovascular events, Hypertriglyceridemia MANUFACTURER: Amarin Pharma Inc USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Vascepa (icosapent ethyl) is a medication used to reduce the risk of cardiovascular events in adults with established cardiovascular disease or elevated triglyceride levels.

Back to Top
Product has been added to your cart